UNSPECIFIED BD MICROFINE PLUS PEN NEEDLE
Report
- Report Number
- 2243072-2021-00401
- Event Type
- Malfunction
- Date Received
- February 18, 2021
- Date of Event
- January 25, 2021
- Report Date
- March 26, 2021
- Manufacturer
- BECTON DICKINSON
- Product Code
- FMI
- PMA / PMN Number
- UNKNOWN
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
H.6. INVESTIGATION: NO SAMPLES (INCLUDING PHOTOS) WERE RETURNED THEREFORE THE COMPLAINT COULD NOT BE CONFIRMED AND THE ROOT CAUSE IS UNDETERMINED. DHR COULD NOT BE PERFORMED DUE TO UNKNOWN LOT#.
IT WAS REPORTED THAT THE UNSPECIFIED BD MICROFINE PLUS¿ PEN NEEDLE WAS DIFFICULT TO OPERATE AND SOMETIMES INJECTED MORE OR LESS THAN "1.5 IU" OF INSULIN LISPRO. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE PATIENT RECEIVED INSULIN LISPRO (RDNA ORIGIN) (HUMALOG) INJECTIONS FROM CARTRIDGE VIA REUSABLE PEN (HUMAPEN LUXURA HD), 1.5 IU AT UNKNOWN FREQUENCY VIA AN UNKNOWN ROUTE, FOR THE TREATMENT OF DIABETES MELLITUS, BEGINNING ON AN UNKNOWN DATE APPROXIMATELY IN (B)(6) 2019. SINCE AN UNKNOWN DATE, WHILE ON INSULIN LISPRO THERAPY, HE (PATIENT'S FATHER) BELIEVED THE PEN SOMETIMES GAVE INSULIN LISPRO LESS AND SOMETIMES GAVE INSULIN LISPRO MORE, WHEN DOSE WAS SET AT 1.5 IU. BD MICROFINE NEEDLE TIP WAS BEING USED. THERE WAS NO CRASHING OR FALLING DOWN OF PEN (B)(4). INFORMATION REGARDING CORRECTIVE TREATMENT AND THE OUTCOME OF THE EVENT WAS NOT PROVIDED. INSULIN LISPRO THERAPY WAS ONGOING. THE OPERATOR OF THE HUMAPEN LUXURA HD AND HIS/ HER TRAINING STATUS WAS NOT PROVIDED. THE HUMAPEN LUXURA HD MODEL DURATION OF USE AND THE REPORTED HUMAPEN LUXURA HD DURATION OF USE WAS NOT PROVIDED BUT STARTED ON AN UNKNOWN DATE IN (B)(6) 2019. THE ACTION TAKEN WITH HUMAPEN LUXURA HD AND ITS RETURN STATUS WAS UNKNOWN. THE REPORTING CONSUMER DID NOT PROVIDE RELATEDNESS FOR THE EVENT WITH INSULIN LISPRO DRUG AND RELATED THE EVENT TO HUMAPEN LUXURA HD."
UNKNOWN MANUFACTURER: (B)(4). DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN. (B)(4).
IT WAS REPORTED THAT THE UNSPECIFIED BD MICROFINE PLUS¿ PEN NEEDLE WAS DIFFICULT TO OPERATE AND SOMETIMES INJECTED MORE OR LESS THAN "1.5 IU" OF INSULIN LISPRO. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE PATIENT RECEIVED INSULIN LISPRO (RDNA ORIGIN) (HUMALOG) INJECTIONS FROM CARTRIDGE VIA REUSABLE PEN (HUMAPEN LUXURA HD), 1.5 IU AT UNKNOWN FREQUENCY VIA AN UNKNOWN ROUTE, FOR THE TREATMENT OF DIABETES MELLITUS, BEGINNING ON AN UNKNOWN DATE APPROXIMATELY IN (B)(6) 2019. SINCE AN UNKNOWN DATE, WHILE ON INSULIN LISPRO THERAPY, HE (PATIENT'S FATHER) BELIEVED THE PEN SOMETIMES GAVE INSULIN LISPRO LESS AND SOMETIMES GAVE INSULIN LISPRO MORE, WHEN DOSE WAS SET AT 1.5 IU. BD MICROFINE NEEDLE TIP WAS BEING USED. THERE WAS NO CRASHING OR FALLING DOWN OF PEN ((B)(4), LOT UNKNOWN). INFORMATION REGARDING CORRECTIVE TREATMENT AND THE OUTCOME OF THE EVENT WAS NOT PROVIDED. INSULIN LISPRO THERAPY WAS ONGOING. THE OPERATOR OF THE HUMAPEN LUXURA HD AND HIS/ HER TRAINING STATUS WAS NOT PROVIDED. THE HUMAPEN LUXURA HD MODEL DURATION OF USE AND THE REPORTED HUMAPEN LUXURA HD DURATION OF USE WAS NOT PROVIDED BUT STARTED ON AN UNKNOWN DATE IN (B)(6) 2019. THE ACTION TAKEN WITH HUMAPEN LUXURA HD AND ITS RETURN STATUS WAS UNKNOWN. THE REPORTING CONSUMER DID NOT PROVIDE RELATEDNESS FOR THE EVENT WITH INSULIN LISPRO DRUG AND RELATED THE EVENT TO HUMAPEN LUXURA HD."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 238189 | UNSPECIFIED BD MICROFINE PLUS PEN NEEDLE | HYPODERMIC SINGLE LUMEN NEEDLE | FMI | BECTON DICKINSON | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |